For pharma giants like Pfizer, Merck & Co, and of course AbbVie, that means a slew of biosimilar versions of their cash cows are about to hit the market, which could seriously undercut revenue
Nat Rev Neurosci 12:88104 Barbeito LH, Pehar M, Cassina P et al (2004) A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis
- Decreased cancers could improve the cost-effectiveness calculations on GLP-1 drugs for obesity, although at current high acquisition prices they are still highly unlikely to be cost-saving
The more consistently you take them, the more its like receiving a daily vitamin drip
Its unique mechanism targets hunger and metabolism, making sticking to your diet plan easier, even if previous weight loss methods have failed